Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $492.7800 (0.52%) ($492.7800 - $492.7800) on Wed. Dec. 23, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.05% (three month average) | RSI | 47 | Latest Price | $492.7800(0.52%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN advances 0.3% a day on average for past five trading days. | Weekly Trend | REGN advances 0.1% a week on average for past two weeks. | Market Behavior | Rotation from growth to value for large cap. Value stock rally for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) IBB(52%) XLV(42%) IVW(36%) SPLV(36%) SPY(36%) | Factors Impacting REGN price | REGN will decline at least -1.025% in a week (0% probabilities). VIXM(-20%) UUP(-7%) TBT(-7%) VXX(-6%) IGOV(-6%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.025% (StdDev 2.05%) | Hourly BBV | 0.1 () | Intraday Trend | 0% | | | |
|
Resistance Level | $496.79 | 5 Day Moving Average | $495.09(-0.47%) | 10 Day Moving Average | $491.46(0.27%) | 20 Day Moving Average | $496.79(-0.81%) | To recent high | -18.9% | To recent low | 2.9% | Market Cap | $52.249b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |